Self-medication among general population in the European Union: prevalence and associated factors

Self-medication involves individuals selecting and using medicines to treat self-recognized health issues without direct medical supervision. It plays a significant role in healthcare systems, especially in the European Union, where it can influence health outcomes and healthcare costs.

This article provides an overview of the current understanding of self-medication practices within the EU, emphasizing the factors that contribute to its prevalence and the implications for public health strategies.

Understanding self-medication behaviors is crucial for developing effective public health interventions and policies. It helps in identifying potential risks and benefits associated with self-medication, ultimately aiming to improve health outcomes and reduce unnecessary healthcare utilization.

By studying these practices, policymakers and healthcare providers can better address issues related to medication safety, resistance, and appropriate healthcare access.

Self-medication impacts public health by influencing medication safety, resistance, and healthcare resource utilization. Recognizing its patterns helps in designing targeted health education and regulation strategies.

Effective management of self-medication can lead to better health outcomes and reduce the burden on healthcare systems.

Insights into self-medication behaviors inform policymakers about necessary regulations and educational campaigns to promote safe medication practices.

Developing policies that regulate over-the-counter medicines and improve public awareness can mitigate risks associated with self-medication.